Top 3 Health Care Stocks That Could Explode This Month

Benzinga and Yahoo Finance LLC may earn commission or revenue for some articles through the links below.

The most oversold healthcare stocks present an opportunity to buy undervalued companies.

RSI is a momentum indicator, which compares a stock’s strength on days when prices rise to strength on days when prices fall. Compared to a stock’s price action, it can give traders a better view of how a stock may perform in the short term. An asset is usually considered oversold when the RSI is below 30, according to Benzinga Pro.

Don’t miss:

Here is the latest list of major oversold players in this sector with an RSI near or below 30.

Progyny Inc (NASDAQ:PGNY)

• On Sept. 19, the company said a customer chose to exercise an option to terminate its service contract with the company. Shares of the company have fallen about 32% in the past five days and are at a 52-week low of $13.93.

• RSI value: 26.50

• PGNY Price Action: Progyny shares rose 1 percent to $16.62 on Friday.

• Benzinga Pro’s real-time news feed has been alerted to the latest PGNY news.

Indivior PLC (NASDAQ:INDV)

• On September 4, Indivior published an update on Aelis Farma’s Phase 2B study of AEF0117 in participants with cannabis use disorder. It has a 52-week low of $9.14.

• RSI value: 25.92

• RELI Price Action: Shares of Indivior fell 2.1% to close at $9.48 on Friday.

• Benzinga Pro’s charting tool helped identify the trend in INDV stocks.

Check: This multi-billion dollar fund invested in the next big real estate boom, here’s how you can sign up for $10.
This is a paid advertisement. Please carefully consider the Fundrise Flagship Fund’s investment objectives, risks, fees and expenses before investing. This and other information can be found in fund prospectus. Read them carefully before investing.

Moderna Inc (NASDAQ:MRNA)

• On September 17, Moderna announced that Health Canada had approved its vaccine, SPIKEVAX, which helps prevent COVID-19 in people six months of age or older. The vaccine targets the KP.2 variant of COVID-19. The company plans to begin shipping the vaccine to the Public Health Agency of Canada soon. “With the recent increase in COVID-19 infections, staying up-to-date on your COVID-19 vaccination remains one of the best ways to help protect yourself from severe illness,” said Dr. Shehzad Iqbal, director country medicine, Moderna Canada. Shares of the company are down about 20% in the past month and have a 52-week low of $62.55.

• RSI value: 28.17

• MRNA Price Action: Moderna shares fell 3.4% to close at $65.69 on Friday.

• Benzinga Pro’s signals feature announced a potential breakout in MRNA stock.

The story continues

Wondering if your investments can take you to a $5,000,000 nest egg? Talk to a financial advisor today. The free SmartAsset tool connects you with up to three verified financial advisors serving your area, and you can interview matched advisors at no cost to decide which one is right for you.

Continue reading:

This article Top 3 Health Care Stocks That Can Explode This Month originally appeared on Benzinga.com